These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22982674)

  • 21. Nucleobindin 2 expression is an independent prognostic factor for clear cell renal cell carcinoma.
    Qi C; Ma H; Zhang HT; Gao JD; Xu Y
    Histopathology; 2015 Apr; 66(5):650-7. PubMed ID: 25322808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of caspase 7 expression is associated with poor prognosis in renal cell carcinoma clear cell subtype.
    Vilella-Arias SA; Rocha RM; da Costa WH; Zequi Sde C; Guimarães GC; Verjovski-Almeida S; Soares FA; Reis EM
    Urology; 2013 Oct; 82(4):974.e1-7. PubMed ID: 23920448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression of COX-2 and VEGF and their correlation with angiogenesis in human clear cell renal cell carcinoma].
    Chang BD; Cao LS; Zhou HL
    Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):687-90. PubMed ID: 20021866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The chromatin remodeling gene ARID1A is a new prognostic marker in clear cell renal cell carcinoma.
    Lichner Z; Scorilas A; White NM; Girgis AH; Rotstein L; Wiegand KC; Latif A; Chow C; Huntsman D; Yousef GM
    Am J Pathol; 2013 Apr; 182(4):1163-70. PubMed ID: 23416164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of CD24 in clear cell renal cell carcinoma and its prognostic significance.
    Lee HJ; Kim DI; Kwak C; Ku JH; Moon KC
    Urology; 2008 Sep; 72(3):603-7. PubMed ID: 18384848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer.
    Dahinden C; Ingold B; Wild P; Boysen G; Luu VD; Montani M; Kristiansen G; Sulser T; Bühlmann P; Moch H; Schraml P
    Clin Cancer Res; 2010 Jan; 16(1):88-98. PubMed ID: 20028743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and significance of FOXP1, HIF-1a and VEGF in renal clear cell carcinoma.
    Wan L; Huang J; Chen J; Wang R; Dong C; Lu S; Wu X
    J BUON; 2015; 20(1):188-95. PubMed ID: 25778315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GATA5 CpG island methylation in renal cell cancer: a potential biomarker for metastasis and disease progression.
    Peters I; Eggers H; Atschekzei F; Hennenlotter J; Waalkes S; Tränkenschuh W; Grosshennig A; Merseburger AS; Stenzl A; Kuczyk MA; Serth J
    BJU Int; 2012 Jul; 110(2 Pt 2):E144-52. PubMed ID: 22289415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD151 expression can predict cancer progression in clear cell renal cell carcinoma.
    Yoo SH; Lee K; Chae JY; Moon KC
    Histopathology; 2011 Jan; 58(2):191-7. PubMed ID: 21323946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of CX3CR1 associates with cellular migration, metastasis, and prognosis in human clear cell renal cell carcinoma.
    Yao X; Qi L; Chen X; Du J; Zhang Z; Liu S
    Urol Oncol; 2014 Feb; 32(2):162-70. PubMed ID: 23570708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome.
    Horiguchi A; Oya M; Shimada T; Uchida A; Marumo K; Murai M
    J Urol; 2002 Aug; 168(2):762-5. PubMed ID: 12131365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic role of pigment epithelium-derived factor in clear cell renal cell carcinoma.
    Jiang Z; Fang Z; Ding Q
    Urol Int; 2010; 84(3):334-40. PubMed ID: 20389166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poor prognosis and advanced clinicopathological features of clear cell renal cell carcinoma (ccRCC) are associated with cytoplasmic subcellular localisation of Hypoxia inducible factor-2α.
    Kroeger N; Seligson DB; Signoretti S; Yu H; Magyar CE; Huang J; Belldegrun AS; Pantuck AJ
    Eur J Cancer; 2014 May; 50(8):1531-40. PubMed ID: 24565854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma.
    Parker AS; Kosari F; Lohse CM; Houston Thompson R; Kwon ED; Murphy L; Riehle DL; Blute ML; Leibovich BC; Vasmatzis G; Cheville JC
    Cancer; 2006 Jul; 107(1):37-45. PubMed ID: 16736510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of Neural Wiskott-Aldrich Syndrome Protein in Clear Cell Renal Cell Carcinoma and Its Correlation with Clinicopathological Features.
    Liu GH; Chen J; Ji ZG; Zhou L
    Urol Int; 2015; 95(1):79-85. PubMed ID: 25115631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ΑB-crystallin in clear cell renal cell carcinoma: tumor progression and prognostic significance.
    Ho PY; Chueh SC; Chiou SH; Wang SM; Lin WC; Lee IL; Yang HY; Peng HC; Lai MK
    Urol Oncol; 2013 Oct; 31(7):1367-77. PubMed ID: 22417627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
    Klatte T; Seligson DB; Riggs SB; Leppert JT; Berkman MK; Kleid MD; Yu H; Kabbinavar FF; Pantuck AJ; Belldegrun AS
    Clin Cancer Res; 2007 Dec; 13(24):7388-93. PubMed ID: 18094421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma.
    Krambeck AE; Dong H; Thompson RH; Kuntz SM; Lohse CM; Leibovich BC; Blute ML; Sebo TJ; Cheville JC; Parker AS; Kwon ED
    Clin Cancer Res; 2007 Mar; 13(6):1749-56. PubMed ID: 17363528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.